PUBLISHER: 360iResearch | PRODUCT CODE: 1435055
PUBLISHER: 360iResearch | PRODUCT CODE: 1435055
[184 Pages Report] The Therapeutic Plasma Exchange Market size was estimated at USD 710.47 million in 2022 and expected to reach USD 792.04 million in 2023, at a CAGR 10.02% to reach USD 1,525.84 million by 2030.
Global Therapeutic Plasma Exchange Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2022] | USD 710.47 million |
Estimated Year [2023] | USD 792.04 million |
Forecast Year [2030] | USD 1,525.84 million |
CAGR (%) | 10.02% |
Therapeutic plasma exchange is a medical procedure that involves removing and separating plasma from the blood to remove harmful substances from the bloodstream, often used to treat a variety of autoimmune and neurological disorders. The market includes medical devices, consumables such as replacement fluids, service providers, hospitals, blood centers, and end-users such as patients requiring these treatments. Therapeutic plasma exchange is primarily applied in the treatment of conditions such as Guillain-Barre syndrome, myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis, among others. End-users of this market can be segmented into hospitals, specialized clinics, and outpatient facilities, which are the primary providers of therapeutic plasma exchange therapy. Growth in the market is influenced by factors such as the increasing prevalence of autoimmune diseases, advancements in healthcare infrastructure, supportive healthcare policies, and the increased effectiveness and safety of plasma exchange procedures. Innovations in apheresis technology and the climbing cases of diseases required, paired with the surge in healthcare investments and beneficial reimbursement climates are market major market upscaling trends. However, challenges such as the elevated cost of TPE procedures, lack of awareness in certain demographics, strict regulatory barriers, and competition from alternative treatments may hinder market progression. However, increased healthcare expenditure and education, and the integration of IT to refine treatment accuracy are lucrative opportunities in the market. To foster growth, the sector is poised for breakthroughs in cost-effective device manufacturing, the application of artificial intelligence for treatment optimization, enhanced apheresis material quality, and exploration of new therapeutic plasma exchange applications, heralding a future of innovation and sustained market vitality.
Regional Insights
The global therapeutic plasma exchange (TPE) market showcases variable maturity in the United States and Europe leading in adoption and innovation, regulated strictly by the FDA and EMA respectively. Market relevance is bolstered by the escalating incidence of autoimmune diseases and critical ailments, matched with increasing investments and consumer demand influenced by factors such as insurance coverage and healthcare infrastructure. Developed nations focus on technological advancements to ameliorate TPE, striving to meet high consumer expectations for safety and efficiency. This growth trajectory, however, is balanced by the challenges of cost management, regulatory compliance, and the necessity for professionally trained personnel. Additionally, research is highly collaborative at the EU level, with numerous cross-border initiatives and funding opportunities, such as those provided by the Horizon Europe program, which supports innovation in the healthcare sector.
Emerging markets such as those in Asia, Africa, and parts of the Americas present significant potential due to rising healthcare investments and less stringent regulatory hurdles, indicating a vast untapped patient demographic.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Therapeutic Plasma Exchange Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Therapeutic Plasma Exchange Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Therapeutic Plasma Exchange Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., Bio Products Laboratory Ltd., Cerus Corporation, Charles River Laboratories International, Inc., CSL Behring, Elastrin Therapeutics, Inc., Fresenius Medical Care AG & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Infomed SA, Kaneka Corporation, Kedrion Biopharma Inc., Mallinckrodt PLC, Medica S.P.A., Medicap Clinic GmbH, MEISE Medizintechnik GmbH, Miltenyi Biotec, Nikkiso Co., Ltd., Pall Corporation, Plasma Technologies, LLC, Qingdao Haier Biomedical Co., Ltd, Sb-Kawasumi Laboratories, Inc., and Terumo BCT, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Therapeutic Plasma Exchange Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Therapeutic Plasma Exchange Market?
3. What are the technology trends and regulatory frameworks in the Therapeutic Plasma Exchange Market?
4. What is the market share of the leading vendors in the Therapeutic Plasma Exchange Market?
5. Which modes and strategic moves are suitable for entering the Therapeutic Plasma Exchange Market?
TABLE 317